Z
605077
vs
S
Shanghai Composite
Over the past 12 months, Zhejiang Huakang Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +5% compared to the Shanghai Composite's +23% growth.
Stocks Performance
605077 vs Shanghai Composite
Performance Gap
605077 vs Shanghai Composite
Performance By Year
605077 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zhejiang Huakang Pharmaceutical Co Ltd
Glance View
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of functional sugar alcohols and starch sugar products. The company is headquartered in Quzhou, Zhejiang and currently employs 1,303 full-time employees. The company went IPO on 2021-02-09. The firm's main products are xylitol, sorbitol, maltitol and grape syrup. Its products are mainly used in food, beverage, daily chemical and other fields. The firm conducts its businesses within the China market and to overseas markets such as Europe, America and Asia.